Author:
Nagase Satoru,Ohta Tsuyoshi,Seino Manabu
Reference84 articles.
1. Piver S, Barlow JJ, Chung WS, Lee FT, Vongtama V. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV. Natl Cancer Inst Monogr. 1975;42:177–82.
2. Fisher RI, Young RC. Advances in the staging and treatment of ovarian cancer. Cancer. 1977;39:967–72.
3. Omura G, Blessing JA, Ehrlich CE, Miller A, Yordan E, Creasman WT, Homesley HD. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. Cancer. 1986;57:1725–30.
4. Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 1989;7:457–65.
5. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol. 1996;23:40–7.